Effect of vitamin D supplementation on bone health in children with blood cancer
Not Applicable
- Conditions
- Health Condition 1: - Health Condition 2: C910- Acute lymphoblastic leukemia [ALL]
- Registration Number
- CTRI/2023/02/049382
- Lead Sponsor
- Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newly diagnosed patients with acute lymphoblastic leukemia
Exclusion Criteria
Relapsed or refractory cases
Pre-existing renal disease
Pre-existing hepatic disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link vitamin D to bone mineral homeostasis in ALL patients undergoing chemotherapy?
How does vitamin D supplementation compare to standard-of-care for bone health in pediatric oncology?
Which biomarkers correlate with improved bone mineralization in ALL patients receiving vitamin D during induction therapy?
What adverse events are associated with high-dose vitamin D in children with acute lymphoblastic leukemia?
Are there combination therapies involving vitamin D and bisphosphonates for managing chemotherapy-induced bone loss in pediatric leukemia?